[go: up one dir, main page]

NO20055393L - Oralt desintegrerende tabletter - Google Patents

Oralt desintegrerende tabletter

Info

Publication number
NO20055393L
NO20055393L NO20055393A NO20055393A NO20055393L NO 20055393 L NO20055393 L NO 20055393L NO 20055393 A NO20055393 A NO 20055393A NO 20055393 A NO20055393 A NO 20055393A NO 20055393 L NO20055393 L NO 20055393L
Authority
NO
Norway
Prior art keywords
orally disintegrating
disintegrating tablets
microcrystalline cellulose
tablet
effective amount
Prior art date
Application number
NO20055393A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055393D0 (no
Inventor
Johannes Jan Platteeuw
Dennie Johan Marijn Van Heuvel
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20055393D0 publication Critical patent/NO20055393D0/no
Publication of NO20055393L publication Critical patent/NO20055393L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20055393A 2003-04-16 2005-11-15 Oralt desintegrerende tabletter NO20055393L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46302703P 2003-04-16 2003-04-16
PCT/EP2004/004119 WO2004091585A1 (fr) 2003-04-16 2004-04-16 Tablettes a desintegration orale

Publications (2)

Publication Number Publication Date
NO20055393D0 NO20055393D0 (no) 2005-11-15
NO20055393L true NO20055393L (no) 2006-01-16

Family

ID=33300032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055393A NO20055393L (no) 2003-04-16 2005-11-15 Oralt desintegrerende tabletter

Country Status (10)

Country Link
US (1) US20040265375A1 (fr)
EP (1) EP1613289A1 (fr)
JP (1) JP2006524650A (fr)
CN (1) CN1787811A (fr)
AU (1) AU2004229177A1 (fr)
CA (1) CA2522100A1 (fr)
NO (1) NO20055393L (fr)
NZ (1) NZ542925A (fr)
WO (1) WO2004091585A1 (fr)
ZA (1) ZA200508361B (fr)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
ATE327744T1 (de) 2001-03-20 2006-06-15 Sanol Arznei Schwarz Gmbh Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz
DE60100055T2 (de) 2001-03-21 2003-07-24 Schwarz Pharma Ag Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
CA2540040C (fr) * 2003-10-07 2012-09-11 Andrx Pharmaceuticals Llc Formulation a desintegration rapide
EP1678139B1 (fr) * 2003-10-10 2011-08-31 Synhton B.V. Montelukast a l'etat solide
CZ300438B6 (cs) * 2003-11-25 2009-05-20 Pliva Hrvatska D.O.O. Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
WO2005070938A1 (fr) * 2004-01-27 2005-08-04 Synthon B.V. Sels stables d'olanzapine
US7658945B2 (en) 2004-02-17 2010-02-09 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US7829716B2 (en) * 2004-04-30 2010-11-09 Synthon Pharmaceuticals, Inc. Process for making montelukast and intermediates therefor
US7501517B2 (en) * 2004-04-30 2009-03-10 Synthon Ip, Inc. Process for making montelukast and intermediates therefor
DE102004028940A1 (de) * 2004-06-15 2006-01-12 Krka Tovarna Zdravil, D.D. Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
MX2007002269A (es) 2004-08-27 2007-06-15 Sanol Arznei Schwarz Gmbh Uso novedoso de compuestos peptidos para tratar dolor por c??ncer de huesos, dolor inducido por quimioterapia y nucleosidos.
US20060078615A1 (en) * 2004-10-12 2006-04-13 Boehringer Ingelheim International Gmbh Bilayer tablet of telmisartan and simvastatin
JP2008517022A (ja) 2004-10-19 2008-05-22 クルカ， トバルナ ズドラビル， デー．デー．， ノボ メスト 塩酸ドネペジルを含有する固形薬学的組成物
GB0423800D0 (en) * 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
WO2006064327A1 (fr) * 2004-12-13 2006-06-22 Mcneil-Ppc, Inc. Compositions et procedes permettant de stabiliser des substances pharmaceutiques actives
NZ555693A (en) 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
CZ297214B6 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
JP2008536922A (ja) * 2005-04-22 2008-09-11 テバ・ファーマシューティカルズ・ユーエスエー・インコーポレイテッド オランザピンの医薬用経口崩壊錠
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
NZ563979A (en) * 2005-05-25 2011-02-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
ZA200710205B (en) * 2005-05-25 2009-03-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
CA2613107A1 (fr) * 2005-06-23 2007-01-04 Spherics, Inc. Formes de dosage de pramipexole a liberation retardee ou a liberation prolongee/retardee
JP2007015966A (ja) * 2005-07-06 2007-01-25 Fujimoto Corporation:Kk 口腔内崩壊錠
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
JP4439499B2 (ja) * 2005-08-01 2010-03-24 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
JP5241681B2 (ja) * 2005-08-01 2013-07-17 大日本住友製薬株式会社 アムロジピン含有粒子およびそれからなる口腔内崩壊錠
KR20130016386A (ko) * 2005-08-10 2013-02-14 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
WO2007020079A2 (fr) * 2005-08-17 2007-02-22 Synthon B.V. Comprimes de simvastatine a desintegration orale
EP1919923A1 (fr) * 2005-08-17 2008-05-14 Synthon B.V. Procede de fabrication d'olanzapine de forme i
GB0518129D0 (en) * 2005-09-06 2005-10-12 Arrow Int Ltd Ramipril formulation
FR2891147B1 (fr) * 2005-09-28 2007-12-07 Ethypharm Sa Comprimes orodispersibles de principes actifs amers
US20070093471A1 (en) * 2005-10-26 2007-04-26 Alamo Pharmaceuticals, Llc Compositions and methods for the administration clozapine formulations which modulate body weight
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
AR056815A1 (es) * 2005-11-18 2007-10-24 Synthon Bv PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST
DE602006008339D1 (en) * 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
DE102005060377A1 (de) * 2005-12-16 2007-06-21 Ratiopharm Gmbh Pharmazeutische Zusammensetzung enthaltend Donepezilhydrochlorid, Tablette hieraus und Verfahren zu deren Herstellung
JP2009519334A (ja) * 2005-12-20 2009-05-14 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール経口崩壊錠剤
EP1978934A1 (fr) * 2005-12-23 2008-10-15 LEK Pharmaceuticals D.D. Granules a rupture
PL1976522T5 (pl) † 2005-12-30 2019-12-31 Krka Tovarna Zdravil, D.D., Novo Mesto Kompozycja farmaceutyczna zawierająca montelukast
RU2490012C2 (ru) * 2006-01-27 2013-08-20 Апталис Фарматех Инк Системы доставки лекарственного средства, содержащие слабощелочной селективный 5-ht3, серотониновый блокатор и органические кислоты
AU2007211101B2 (en) * 2006-01-27 2013-05-02 Adare Pharmaceuticals, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
EP1815857A1 (fr) * 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. Composition pharmaceutique comprenant du perindopril
CN101432267A (zh) * 2006-03-17 2009-05-13 斯索恩有限公司 孟鲁司特金刚烷胺盐
KR101470483B1 (ko) * 2006-03-24 2014-12-08 코와 가부시키가이샤 구강내 신속 붕괴성 정제
WO2007134845A2 (fr) * 2006-05-18 2007-11-29 Synthon B.V. Composition pharmaceutique d'olanzapine
US20070281014A1 (en) * 2006-06-01 2007-12-06 Cima Labs, Inc. Prednisolone salt formulations
US8637076B2 (en) * 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
KR20150003925A (ko) 2006-06-15 2015-01-09 유씨비 파르마 게엠베하 상승적 항경련 효과를 갖는 약제학적 조성물
EP2040676A2 (fr) * 2006-07-06 2009-04-01 Forest Laboratories, Inc. Formulations à dissolution orale de mémantine
JP2008044870A (ja) * 2006-08-11 2008-02-28 Elmed Eisai Kk 医薬組成物及びその製造方法
AR063043A1 (es) * 2006-09-29 2008-12-23 Synthon Bv Composicion farmaceutica de olanzapina
BRMU8602968U (pt) * 2006-11-16 2008-09-30 Jr Walter Santos medicamento "ramipril + metformina" em forma combinada para doenças cardiovasculares
WO2008058355A2 (fr) * 2006-11-16 2008-05-22 Walter Santos Junior Combinaison médicamenteuse 'atorvastatine + metformine' utilisée pour lutter contre les maladies cardiovasculaires
IES20070122A2 (en) * 2006-12-05 2008-05-28 Michael Hilary Burke A process for the preparation of an orally administered unit dose tablet
TW200835527A (en) * 2006-12-26 2008-09-01 Shionogi & Co Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
US20090074862A1 (en) 2007-04-13 2009-03-19 Luigi Schioppi Low-dose doxepin formulations and methods of making and using the same
EP1997480A1 (fr) * 2007-06-01 2008-12-03 The Jordanian Pharmaceutical Manufacturing Co. Dispersion solide de fibre minérale, son procédé de préparation et utilisation comme fabrication de comprimés pharmaceutiques
TWI547282B (zh) * 2007-07-02 2016-09-01 愛戴爾製藥股份有限公司 樂命達之口服分解錠劑組合物
EP2044929A1 (fr) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Comprimés oraux à désintégration rapide
ES2455195T3 (es) * 2007-11-21 2014-04-14 Dainippon Sumitomo Pharma Co., Ltd. Comprimido que se disgrega en la cavidad oral
JP2011506279A (ja) * 2007-12-08 2011-03-03 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 経口で分散可能な錠剤
JP2009196940A (ja) * 2008-02-22 2009-09-03 Takada Seiyaku Kk 口腔内速崩壊錠及びその製造法
WO2009130056A1 (fr) * 2008-04-25 2009-10-29 Synthon B.V. Procédé pour préparer des intermédiaires de montélukast
US20100016265A1 (en) * 2008-07-16 2010-01-21 Qaiser Yusuf Anti-inflammatory composition and method for preparation
CN101766605B (zh) * 2008-12-29 2014-02-19 北京德众万全药物技术开发有限公司 包含普拉克索的可在口中分散的药物组合物
EP2410995A1 (fr) 2009-03-26 2012-02-01 Royal College of Surgeons in Ireland Comprimés orodispersibles
TR200903293A1 (tr) * 2009-04-28 2010-11-22 Sanovel İlaç San. Ve Ti̇c. A.Ş. Oral yolla dağılan olanzapin tablet.
EP2440210A4 (fr) 2009-06-12 2014-01-29 Meritage Pharma Inc Procédés de traitement de troubles gastro-intestinaux
KR101074271B1 (ko) * 2009-06-25 2011-10-17 (주)차바이오앤디오스텍 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
EP2477609A1 (fr) * 2009-09-15 2012-07-25 Ratiopharm GmbH Forme pharmaceutique à délitement oral contenant de l'aripiprazole
RS59241B1 (sr) 2009-10-01 2019-10-31 Adare Development I L P Kortikosteroidne kompozicije za oralnu administraciju
TR200907554A1 (tr) * 2009-10-06 2011-04-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Oral yolla dağılan pramıpexole bileşimleri.
CN102058549B (zh) * 2009-11-17 2014-08-27 北京万全阳光医学技术有限公司 一种含非那雄胺的口腔崩解片及其制备方法
CN101716151B (zh) * 2009-12-24 2012-06-27 杭州康恩贝制药有限公司 一种快速溶出的非那雄胺口服片剂及制备方法
EP2524689B1 (fr) * 2009-12-28 2016-10-05 Nipro Corporation Procédé de préparation de tablettes de donepezil
JP2011213695A (ja) * 2010-04-02 2011-10-27 Taisho Pharm Ind Ltd ドネペジル塩酸塩含有口腔内速崩壊錠
WO2012003987A1 (fr) * 2010-07-08 2012-01-12 Ratiopharm Gmbh Forme posologique orale de déférasirox
AU2010363329A1 (en) * 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
EP2468254A1 (fr) * 2010-12-15 2012-06-27 Hexal AG Comprimé à désintégration orale doté d'un effet de masquage du goût
CN102727452B (zh) * 2011-04-01 2014-12-24 成都康弘药业集团股份有限公司 一种含右佐匹克隆的颗粒及其制备方法
WO2013095314A1 (fr) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations pharmaceutiques comprenant de la rispéridone
JP6062693B2 (ja) * 2012-09-14 2017-01-18 沢井製薬株式会社 オランザピン含有製剤
WO2014090386A1 (fr) * 2012-12-11 2014-06-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Comprimé à désintégration orale contenant de l'asénapine
WO2014135967A1 (fr) 2013-03-06 2014-09-12 Capsugel Belgium Nv Particules lipidiques solides de curcumine et procédés de préparation et utilisation
US20150025112A1 (en) * 2013-07-19 2015-01-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of donepezil
WO2015034678A2 (fr) * 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticostéroïde contenant des compositions de comprimés se désintégrant par voie orale pour œsophagite à éonisophiles
WO2015077535A2 (fr) * 2013-11-22 2015-05-28 Genzyme Corporation Nouvelles méthodes pour traiter des maladies neurodégénératives
CN104784047B (zh) * 2014-01-16 2018-09-21 南京瑞尔医药有限公司 一种非那雄胺组合物
CN105012253A (zh) * 2014-04-24 2015-11-04 南京长澳医药科技有限公司 一种盐酸普拉克索口腔崩解片及其制备方法
EP3766480A1 (fr) * 2014-06-10 2021-01-20 Capsugel Belgium NV Comprimé à désintégration orale contenant des particules lipidiques solides, et son procédé de préparation et d'utilisation
CN104027319A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 一种塞来昔布分散片及其制备方法
US20170252295A1 (en) 2014-09-17 2017-09-07 Steerlife India Private Limited Effervescent composition and method of making it
JP2016079120A (ja) * 2014-10-15 2016-05-16 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 包装により安定性が改善されたオランザピン製剤
CN104382895A (zh) * 2014-10-22 2015-03-04 湖南明瑞制药有限公司 一种辛伐他汀组合物
CN104523645A (zh) * 2014-11-20 2015-04-22 美吉斯制药（厦门）有限公司 甲磺酸帕罗西汀片芯及其包衣片的制备方法
WO2016087261A1 (fr) 2014-12-04 2016-06-09 Capsugel Belgium N.V. Formulations multiparticulaires lipidiques
EP3238712B1 (fr) * 2014-12-25 2023-11-01 Daicel Corporation Comprimé à désagrégation très rapide, et son procédé de production
CN104771761A (zh) * 2015-03-19 2015-07-15 深圳国源国药有限公司 一种创新药用辅料硅化微晶纤维素及其制备方法
CN105147627B (zh) * 2015-08-19 2019-04-12 天津红日药业股份有限公司 一种含有盐酸普拉克索的药物组合物及其制备方法
WO2017098481A1 (fr) 2015-12-12 2017-06-15 Steerlife India Private Limited Compositions effervescentes de metformine et leurs procédés de préparation
RU2619213C1 (ru) * 2016-01-25 2017-05-12 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма зафирлукаста немедленного высвобождения и способ ее получения
US11110035B1 (en) 2016-02-05 2021-09-07 Gram Tactical Llc Tactical medicine dispensers
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CN108938580B (zh) * 2017-05-26 2022-09-27 万全万特制药江苏有限公司 盐酸帕罗西汀口崩片
CN109864975B (zh) * 2017-12-04 2021-10-08 成都康弘药业集团股份有限公司 一种阿立哌唑的口腔崩解片及其制备方法
JP2021517150A (ja) * 2018-03-11 2021-07-15 ナノロジカ アーベー 圧縮医薬剤形にて使用するための多孔質シリカ粒子
CN110840850B (zh) * 2018-07-24 2023-03-17 烟台药物研究所 一种高生物利用度的塞来昔布冻干口崩片及其制备方法
WO2020049505A1 (fr) 2018-09-06 2020-03-12 Innopharmascreen Inc. Procédés et compositions pour le traitement de l'asthme ou de la maladie de parkinson
JP7219979B2 (ja) * 2020-02-26 2023-02-09 日新製薬株式会社 被覆層を有する口腔内崩壊錠
GB2636158A (en) * 2023-12-01 2025-06-11 Novumgen Ltd An orally disintegrating tablet containing amlodipine or pharmaceutically acceptable salts thereof and the process of preparing the same
GB2636182A (en) * 2023-12-04 2025-06-11 Novumgen Ltd An orally disintegrating tablet of paroxetine and its process of preparation

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US50312A (en) * 1865-10-03 Improvement in handle attachments to small-arms
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US6471994B1 (en) * 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
ES2559766T3 (es) * 1998-05-18 2016-02-15 Takeda Pharmaceutical Company Limited Comprimidos disgregables en la boca
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
WO2001039746A1 (fr) * 1999-12-06 2001-06-07 Edward Mendell Co., Inc. Super-desintegrant pharmaceutique
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
DK1522539T3 (da) * 2001-07-31 2007-05-07 Lundbeck & Co As H Krystallinsk komposition indeholdende excitalopram
MXPA04007428A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete

Also Published As

Publication number Publication date
ZA200508361B (en) 2006-12-27
US20040265375A1 (en) 2004-12-30
JP2006524650A (ja) 2006-11-02
NO20055393D0 (no) 2005-11-15
NZ542925A (en) 2007-04-27
CA2522100A1 (fr) 2004-10-28
EP1613289A1 (fr) 2006-01-11
AU2004229177A1 (en) 2004-10-28
WO2004091585A1 (fr) 2004-10-28
CN1787811A (zh) 2006-06-14

Similar Documents

Publication Publication Date Title
NO20055393L (no) Oralt desintegrerende tabletter
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
WO2004000197A3 (fr) Compositions a dissolution rapide et comprimes bases sur ces compositions
NO20081843L (no) Farmasoytisk sammensetning for forbedret kognitiv funksjon
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
TW200633730A (en) Oral disintegrating dosage forms
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
TR200002207T1 (tr) Slekoksib bileşikleri.
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
ATE370727T1 (de) Pharmazeutische suspensionstabletten- zusammenstellungen
MXPA04005105A (es) Formulaciones de acitromicina directamente compresibles.
AR053440A2 (es) Uso de una forma de dosificacion farmaceutica de liberacion sostenida para la manufactura de un medicamento, dicha forma de dosificacion farmaceutica y una tableta comprimida
CA2505964A1 (fr) Compositions pharmaceutiques et formes de dosage de la thalidomide
CO5070643A1 (es) Formulacion en tabletas comprimidas
HUP0102676A2 (hu) Szilárd, gyorsan széteső cetirizint tartalmazó gyógyszerkészítmények
AP2004002999A0 (en) Organoleptically acceptable intraorally disintegrating compositions
HUP0402577A2 (hu) Citoszol foszfolipáz A2 inhibitor hatású indolszármazékok, eljárás előállításukra
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
DE602004004782D1 (de) Schnell wasserdispergierbare und Domperidon enthaltende Tabletten
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application